Despite considerable evidence supporting the use of antiretroviral therapy (ART) for prevention of HIV and TB illness, death and transmission, only 37 percent of the 35 million people living with HIV were receiving it in 2013. This paper examines ongoing and planned global treatment as prevention studies and addresses research questions related to access and implementation.
Antiretroviral Treatment for Prevention of HIV and Tuberculosis
Ongoing and Planned PrEP Demonstration and Implementation Studies
This is a summary table of ongoing and planned global PrEP evaluation studies.
Global Investment in HIV Cure Research and Development in 2012
In 2013 the International AIDS Society HIV Cure Resource Tracking group joined with the HIV Vaccines and Microbicides Tracking Working Group to estimate global investments in HIV cure research and produce this short report.
Rectal Microbicides Video Facilitator’s Guide
This guide is meant to be used as a preparation tool for people leading community discussions, workshops, or recruitment sessions who will be showing the educational video. Background information on rectal microbicide research and the clinical trial process is included in the guide.
Rectal Microbicides Video Facilitator’s Guide (Spanish)
This guide is meant to be used as a preparation tool for people leading community discussions, workshops, or recruitment sessions who will be showing the educational video in Spanish. Background information on rectal microbicide research and the clinical trial process is included in the guide.
Rectal Microbicides Video Facilitator’s Guide (Thai)
This guide is meant to be used as a preparation tool for people leading community discussions, workshops, or recruitment sessions who will be showing the educational video in Thai. Background information on rectal microbicide research and the clinical trial process is included in the guide.
The GLAM Toolkit: Advocacy to improve access to safe, condom-compatible lubricant in Africa
The GLAM Toolkit: Advocacy to improve access to safe, condom-compatible lubricant in Africa” published by IRMA, amfAR and AVAC, provides background on the status of lubricant (lube) access in Africa and suggests potential strategies for civil society and government partners to secure and distribute sustainable supplies of safe, condom-compatible lube. Global Lube Access Mobilisation (GLAM) is a campaign of IRMA’s Project ARM (Africa for Rectal Microbicides) initiative.
The GLAM Toolkit: Advocacy to improve access to safe, condom-compatible lubricant in Africa (French)
“La boîte à outils GLAM – Plaidoyer pour améliorer l’accès en Afrique à du lubrifiant fiable et adapté au préservatif”, published by IRMA, amfAR and AVAC, provides background on the status of lubricant (lube) access in Africa and suggests potential strategies for civil society and government partners to secure and distribute sustainable supplies of safe, condom-compatible lube. Global Lube Access Mobilisation (GLAM) is a campaign of IRMA’s Project ARM (Africa for Rectal Microbicides) initiative.
MTN-017 Trial Launch Webinar
Be the Generation Bridge and International Rectal Microbicide Advocates (IRMA) hosted a webinar to mark the launch of MTN-017, the first-ever phase II safety study of a rectal microbicide. Ross D. Cranston, MD, of the University of Pittsburgh School of Medicine and co-leader of MTN-017, presented on the trial details, followed by Jim Pickett of IRMA who presented on the community engagement activities undertaken in support of the trial.
On the Map: Ensuring Africa’s Place in Rectal Microbicide Advocacy
IRMA hosted a strategy development meeting on 2-3 December 2011 in Addis Ababa, Ethiopia to develop an African rectal microbicide agenda that articulates research, advocacy, and community mobilization strategies. The strategy meeting brought together African stakeholders and allies representing a wide array of perspectives, experiences, and geographies to develop action steps for RM research and advocacy, specific to the African context.